Literature DB >> 15669043

Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates.

R M Dawson1.   

Abstract

Ganglioside GM1 is the receptor for cholera toxin on cell surfaces, and the binding of cholera toxin to GM1 immobilized on microtitre plates has been reported previously by several authors as an assay for the toxin (GM1-ELISA). This assay has been examined in detail. Results were independent of the adsorption solvent for GM1 (methanol or phosphate-buffered saline), the pH of aqueous solvents (7.4-10.2) and the temperature (4-37 degrees C). High and near-maximal rates of absorbance change in the assay were found for lower concentrations of GM1 (100 ng ml(-1)) and for shorter incubation times (a few hours) than reported in the literature. A method was devised to provide a semi-quantitative estimate of the amount of GM1 bound to the plate; this was found to be in the low nanogram range. Binding of cholera toxin to the immobilized GM1 required > or =1.5 h for maximal assay results. The failure of free GM1 in solution to displace cholera toxin once bound to immobilized GM1 indicated that binding to immobilized GM1 is irreversible in the time frame of the experiment. Data from the literature support the very slow dissociation rates of the toxin-GM1 complex. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669043     DOI: 10.1002/jat.1015

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  11 in total

1.  High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds.

Authors:  Siddharth Tiwari; Devesh K Mishra; Sribash Roy; Ankit Singh; P K Singh; Rakesh Tuli
Journal:  Plant Cell Rep       Date:  2009-10-10       Impact factor: 4.570

2.  Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.

Authors:  Robert K Yu; Seigo Usuki; Yutaka Itokazu; Han-Chung Wu
Journal:  Glycobiology       Date:  2015-09-24       Impact factor: 4.313

Review 3.  Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER.

Authors:  Daniel J-F Chinnapen; Himani Chinnapen; David Saslowsky; Wayne I Lencer
Journal:  FEMS Microbiol Lett       Date:  2006-11-29       Impact factor: 2.742

4.  Gut microbiome ADP-ribosyltransferases are widespread phage-encoded fitness factors.

Authors:  Eric M Brown; Hugo Arellano-Santoyo; Emily R Temple; Zachary A Costliow; Matthieu Pichaud; A Brantley Hall; Kai Liu; Michael A Durney; Xiebin Gu; Damian R Plichta; Clary A Clish; Jeffrey A Porter; Hera Vlamakis; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2021-08-16       Impact factor: 31.316

5.  A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein response.

Authors:  Joshua M Royal; Young Jun Oh; Michael J Grey; Wayne I Lencer; Nemencio Ronquillo; Susan Galandiuk; Nobuyuki Matoba
Journal:  FASEB J       Date:  2019-09-27       Impact factor: 5.834

6.  CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway.

Authors:  Katie L Alexander; Jannet Katz; Charles O Elson
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 7.  Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa.

Authors:  Joshua M Royal; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2017-11-23       Impact factor: 4.546

8.  In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses.

Authors:  Moeko Kohyama; Akira Yabuki; Kenji Ochiai; Yuya Nakamoto; Kazuyuki Uchida; Daisuke Hasegawa; Kimimasa Takahashi; Hiroaki Kawaguchi; Masaya Tsuboi; Osamu Yamato
Journal:  BMC Vet Res       Date:  2016-03-31       Impact factor: 2.741

Review 9.  Plants as bioreactors for the production of vaccine antigens.

Authors:  Siddharth Tiwari; Praveen C Verma; Pradhyumna K Singh; Rakesh Tuli
Journal:  Biotechnol Adv       Date:  2009-04-06       Impact factor: 14.227

10.  Repeated Oral Administration of a KDEL-tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis Despite a Robust Immunogenic Response.

Authors:  Joshua M Royal; Micaela A Reeves; Nobuyuki Matoba
Journal:  Toxins (Basel)       Date:  2019-11-20       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.